User profiles for "author:S Srinivas"

Sangly P. Srinivas

- Verified email at indiana.edu - Cited by 3797

Sharan Srinivas

- Verified email at missouri.edu - Cited by 1355

[HTML][HTML] Current trends and challenges in cancer management and therapy using designer nanomaterials

PN Navya, A Kaphle, SP Srinivas, SK Bhargava… - Nano convergence, 2019 - Springer
Nanotechnology has the potential to circumvent several drawbacks of conventional
therapeutic formulations. In fact, significant strides have been made towards the application …

Air taxi service for urban mobility: A critical review of recent developments, future challenges, and opportunities

S Rajendran, S Srinivas - Transportation research part E: logistics and …, 2020 - Elsevier
Expected to operate in the imminent future, air taxi service (ATS) is an aerial on-demand
transport for a single passenger or a small group of riders, which seeks to transform the …

NCCN task force report: bone health in cancer care

…, G Litsas, R McKay, DA Podoloff, S Srinivas… - Journal of the National …, 2013 - jnccn.org
Bone health and maintenance of bone integrity are important components of comprehensive
cancer care. Many patients with cancer are at risk for therapy-induced bone loss, with …

[HTML][HTML] Nivolumab versus everolimus in advanced renal-cell carcinoma

…, S George, HJ Hammers, S Srinivas… - … England Journal of …, 2015 - Mass Medical Soc
Background Nivolumab, a programmed death 1 (PD-1) checkpoint inhibitor, was associated
with encouraging overall survival in uncontrolled studies involving previously treated …

Atezolizumab in patients with locally advanced and metastatic urothelial carcinoma who have progressed following treatment with platinum-based chemotherapy: a …

…, PH O'Donnell, A Balmanoukian, Y Loriot, S Srinivas… - The Lancet, 2016 - thelancet.com
Background Patients with metastatic urothelial carcinoma have few treatment options after
failure of platinum-based chemotherapy. In this trial, we assessed treatment with …

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

…, MS Van der Heijden, R Dreicer, S Srinivas… - The Lancet, 2017 - thelancet.com
Background First-line chemotherapy for patients with cisplatin-ineligible locally advanced or
metastatic urothelial carcinoma is associated with short response duration, poor survival …

[HTML][HTML] Cre reporter strains produced by targeted insertion of EYFP and ECFP into the ROSA26 locus

S Srinivas, T Watanabe, CS Lin, CM William… - BMC developmental …, 2001 - Springer
Abstract Background Several Cre reporter strains of mice have been described, in which a
lacZ gene is turned on in cells expressing Cre recombinase, as well as their daughter cells …

Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology

…, A Shabsigh, EJ Small, DE Spratt, S Srinivas… - Journal of the National …, 2019 - jnccn.org
The NCCN Guidelines for Prostate Cancer include recommendations regarding diagnosis,
risk stratification and workup, treatment options for localized disease, and management of …

Bending, vibration and buckling of simply supported thick orthotropic rectangular plates and laminates

S Srinivas, AK Rao - International Journal of Solids and Structures, 1970 - Elsevier
This paper presents a unified exact analysis for the statics and dynamics of a class of thick
laminates. A three-dimensional, linear, small deformation theory of elasticity solution is …

Efficacy and safety of durvalumab in locally advanced or metastatic urothelial carcinoma: updated results from a phase 1/2 open-label study

…, MN Fishman, J Zhang, S Srinivas… - JAMA …, 2017 - jamanetwork.com
Importance The data reported herein were accepted for assessment by the US Food and
Drug Administration for Biologics License Application under priority review to establish the …